The challenges of conducting effective pharmaceutical market research in emerging markets

Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets

Emerging markets present an exciting opportunity for growth for the pharmaceutical industry, as traditional Western markets mature and there are a limited number of new products in the pipeline offering blockbuster revenues.

Some of the emerging markets, such as the BRIC nations of Brazil, Russia, India and China, are experiencing double-digit growth, as well as burgeoning public and private health care systems. A demographic of wealthy urban patients who can afford better-quality health care is on the rise, with an appetite for Western lifestyles and products.

http://www.researchpartnership.com/news/2016/05/article-best-practices-in-em/